バイオ医薬品スタートアップの成功を促進するためのホリスティックなエコシステム戦略
Beatrice Bader1, Maximillian Zinner1, Hubert Trübel2
1Faculty of Health, Witten/Herdecke University, Witten, Germany.
Abstract:
Biopharma start-ups drive pharmaceutical innovation, relying on local ecosystems that connect key actors, resources, and enabling factors. This article synthesizes literature and expert insights into a framework that outlines five pillars-networks, technology transfer, funding, education, and culture-to guide policymakers and stakeholders in building thriving biopharma clusters and accelerating innovation.
さらに関連する動画
関連する概念動画
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioremediation
Drug Products: Biologics, Biosimilars and Interchangeables
Biopharmaceutics and Pharmacokinetics: Overview
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems


